These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15689228)

  • 1. Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population.
    Tran TN; Liu Y; Takagi M; Yamaguchi A; Fujii H
    J Oral Pathol Med; 2005 Mar; 34(3):150-6. PubMed ID: 15689228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
    Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
    Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOH at chromosome 9q34.3 and the Notch1 gene methylation are less involved in oral squamous cell carcinomas.
    Gao S; Krogdahl A; Eiberg H; Liu CJ; Sørensen JA
    J Oral Pathol Med; 2007 Mar; 36(3):173-6. PubMed ID: 17305639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cell Mol Med; 2006; 10(3):778-88. PubMed ID: 16989737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
    Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
    BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
    Wang J; Lee JJ; Wang L; Liu DD; Lu C; Fan YH; Hong WK; Mao L
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6119-25. PubMed ID: 15447998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma.
    Bazan V; Zanna I; Migliavacca M; Sanz-Casla MT; Maestro ML; Corsale S; Macaluso M; Dardanoni G; Restivo S; Quintela PL; Bernaldez R; Salerno S; Morello V; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 Sep; 192(3):286-93. PubMed ID: 12124774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
    Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
    Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
    Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
    Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM
    Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients.
    Chan MW; Chan LW; Tang NL; Lo KW; Tong JH; Chan AW; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
    Int J Cancer; 2003 May; 104(5):611-6. PubMed ID: 12594816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.